What will be the economic impact of the H5N1 outbreak on Georgia's poultry industry by the end of 2025?
Severe impact • 25%
Moderate impact • 25%
Minimal impact • 25%
No significant impact • 25%
Economic reports and analysis from Georgia's agricultural sector
Georgia Halts Poultry Sales After H5N1 Bird Flu Outbreak in Elbert County Affects 45,000 Chickens
Jan 18, 2025, 04:41 PM
Georgia has confirmed its first case of Highly Pathogenic Avian Influenza (HPAI) of the H5N1 strain in a commercial poultry operation, leading to a statewide suspension of all poultry sales and related activities. The outbreak was detected in Elbert County, affecting 45,000 chickens. This marks the fifth instance of the virus in Georgia but the first in a commercial setting since the ongoing outbreak began in 2022. In response, the Georgia Department of Agriculture has deployed emergency teams to manage the situation, including cleaning, disinfecting, and disposal operations. All commercial poultry operations within a 6.2-mile radius of the affected site are under quarantine and will undergo surveillance testing for at least two weeks. The state's poultry industry, Georgia's #1 industry, faces a serious threat, prompting officials to work around the clock to mitigate the spread and resume normal activities as soon as possible.
View original story
Severe impact (more than 20% revenue loss) • 25%
Significant impact (10-20% revenue loss) • 25%
Moderate impact (5-10% revenue loss) • 25%
Minimal impact (less than 5% revenue loss) • 25%
Less than $50 million • 25%
More than $200 million • 25%
$100 million to $200 million • 25%
$50 million to $100 million • 25%
Severe impact • 25%
Mild impact • 25%
Moderate impact • 25%
No impact • 25%
Significant • 25%
Minimal • 25%
Severe • 25%
Moderate • 25%
Missouri • 25%
Texas • 25%
California • 25%
Other • 25%
Mild impact • 25%
Very severe impact • 25%
Severe impact • 25%
Moderate impact • 25%
Minor reduction in exports • 25%
Major reduction in exports • 25%
Moderate reduction in exports • 25%
No significant impact • 25%
Yes • 50%
No • 50%
Minor impact • 25%
Moderate impact • 25%
Severe impact • 25%
No impact • 25%
Moderate impact ($10-50 million loss) • 25%
Significant impact ($50-100 million loss) • 25%
Minimal impact (less than $10 million loss) • 25%
Severe impact (over $100 million loss) • 25%
Production partially recovers • 25%
Production fully recovers • 25%
Production remains significantly reduced • 25%
Production declines further • 25%
Vaccine approved and available • 25%
Vaccine in clinical trials • 25%
Vaccine in development stage • 25%
No vaccine progress • 25%
No • 50%
Yes • 50%
Public awareness campaigns • 25%
Stricter biosecurity measures • 25%
No significant new measures • 25%
Increased surveillance and testing • 25%